Perella Weinberg Partners, an independent advisory firm, provides strategic and financial advice services in the United States, the United Kingdom, and internationally. It offers advisory services related to strategic and financial decisions, mergers and acquisition execution, shareholder engagement advisory, and financing and capital solutions advice with a focus on restructuring, liability management, capital markets advisory, and private capital placement, as well as underwriting and research services primarily for the energy and related industries. The company serves public multinational corporations, mid-sized public and private companies, financial sponsors, individual entrepreneurs, private and institutional investors, creditor committees, and government institutions in consumer and retail; energy and energy transition; financial services and FinTech; healthcare; industrials and infrastructure; and technology, telecommunication, and media industries. Perella Weinberg Partners is headquartered in New York, New York.…
Perella Weinberg Partners (PWP) Earnings Strength Raises Fresh Questions About Valuation
Perella Weinberg Partners (NASDAQ: PWP) is listed on Nasdaq, where its shares trade in USD. It belongs to the Capital Markets industry, part of the Financial Services sector, and reports about 736 employees.
The shares were at 11.77 USD on 20 November 2026, down 37.1% over 52 weeks. Its 52-week range is 11.75 USD to 25.92 USD, and it trades at the bottom of that range.
At a market capitalisation of 1.19B USD, it trades at 30.2 times trailing earnings and 7.9 times forward earnings. The median trailing P/E of its 20 largest Capital Markets peers is 15.0, a premium of 101% for PWP. It pays a dividend yielding 2.28% (it pays out 72% of its earnings), against a median of 2.01% among the dividend payers in that peer group.
Perella Weinberg Partners reports return on equity of -27.9%, an operating margin of 8.5% and revenue up 52.7% year over year.
Its debt exceeds its cash by 29.14M USD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 4 analysts cover the stock, with an average rating of Hold; their mean price target of 21.00 USD is 78.4% above the current price. The next earnings report is expected on 5 February 2027.